- Home
- TXMD vs SYTA Comparison
TXMD vs SYTA Comparison
Compare TXMD & SYTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- SYTA
- Stock Information
- Founded
- TXMD 2008
- SYTA N/A
- Country
- TXMD United States
- SYTA Canada
- Employees
- TXMD N/A
- SYTA N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- SYTA Telecommunications Equipment
- Sector
- TXMD Health Care
- SYTA Telecommunications
- Exchange
- TXMD Nasdaq
- SYTA Nasdaq
- Market Cap
- TXMD 13.5M
- SYTA 10.7M
- IPO Year
- TXMD N/A
- SYTA 2020
- Fundamental
- Price
- TXMD $1.17
- SYTA $4.29
- Analyst Decision
- TXMD
- SYTA
- Analyst Count
- TXMD 0
- SYTA 0
- Target Price
- TXMD N/A
- SYTA N/A
- AVG Volume (30 Days)
- TXMD 35.3K
- SYTA 3.6M
- Earning Date
- TXMD 08-11-2025
- SYTA 08-15-2025
- Dividend Yield
- TXMD N/A
- SYTA N/A
- EPS Growth
- TXMD N/A
- SYTA N/A
- EPS
- TXMD N/A
- SYTA N/A
- Revenue
- TXMD $1,841,000.00
- SYTA $11,740,024.00
- Revenue This Year
- TXMD $427.09
- SYTA $18.41
- Revenue Next Year
- TXMD N/A
- SYTA N/A
- P/E Ratio
- TXMD N/A
- SYTA N/A
- Revenue Growth
- TXMD 53.55
- SYTA 33.58
- 52 Week Low
- TXMD $0.70
- SYTA $0.93
- 52 Week High
- TXMD $2.44
- SYTA $162.90
- Technical
- Relative Strength Index (RSI)
- TXMD 47.76
- SYTA 62.85
- Support Level
- TXMD $1.13
- SYTA $3.70
- Resistance Level
- TXMD $1.24
- SYTA $4.68
- Average True Range (ATR)
- TXMD 0.09
- SYTA 0.63
- MACD
- TXMD 0.01
- SYTA 0.22
- Stochastic Oscillator
- TXMD 73.12
- SYTA 73.46
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About SYTA Siyata Mobile Inc.
Siyata Mobile Inc is engaged in the sale of vehicle mounted, cellular-based communications platforms over advanced 3G (Third generation) mobile networks and cellular booster systems. The company develops, markets and sells a portfolio of rugged handheld Push-to-Talk over Cellular (PoC) smartphone devices. These rugged business-to-business (B2B) environments are focused on enterprise customers, first responders, construction workers, security guards, government agencies, utilities, transportation and waste management, amusement parks, and mobile workers in multiple industries. The company operates in USA, Canada, EMEA and Australia. It derives maximum revenue from USA.